CE Instructions for
WB4460: COVID-19 Vaccine Training: General Overview of Immunization Best Practices for Healthcare Providers
(Credit expires 12/15/2022)

Due to the ever-changing dynamics of COVID vaccine, content is subject to change. Please refer back to the online course for the most up-to-date content.

To receive continuing education (CE)
In order to receive continuing education (CE) for WB4460 COVID-19 Vaccine Training: General Overview of Immunization Best Practices for Healthcare Providers, please visit TCEO at www.cdc.gov/getCE and follow the 9 Simple Steps by 12/15/2022. Pass the posttest at 80%.

If you have any questions or problems, contact CDC/ATSDR Training and Continuing Education Online via email at ce@cdc.gov. You may also contact the CE Coordinator at NCIRD, Melissa Barnett at MBarnett2@cdc.gov

PROGRAM DESCRIPTION: CDC has created a new, web-on-demand, self-paced module for healthcare providers who will be administering Pfizer-BioNTech COVID-19 Vaccine. This module will provide information to healthcare professionals about COVID-19 vaccine manufactured by Pfizer Pharmaceuticals, based on the recommendations of the Advisory Committee on Immunization Practices and guidance from the manufacturer.

OBJECTIVES: At the conclusion of the session, the participant will be able to:
Describe the Vaccine Safety, Development, and Emergency Use Authorization (EUA) mechanism to provide approval for COVID-19 vaccines.
Describe the general storage and handling requirements for COVID-19 vaccines.
Describe the general vaccine administration procedures for COVID-19 vaccines.
Describe documentation and reporting procedures for adverse events associated with COVID-19 Vaccines.
Locate current immunization resources to increase knowledge of team’s role in program implementation for improved team performance.
Implement disease detection and prevention health care services (e.g., smoking cessation, weight reduction, diabetes screening, blood pressure screening, immunization services) to prevent health problems and maintain health.

FACULTY/CREDENTIALS:
Andrew Kroger, MD, MPH, Medical Officer, CDC/NCIRD
JoEllen Wolicki, BSN, RN, Nurse Educator, CDC/NCIRD

ORIGINATION DATE: 12/15/2020 EXPIRATION DATE: 12/15/2022

URL: https://www2.cdc.gov/vaccines/ed/covid19/pfizer/index.asp
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser; MATERIALS: Internet connection and computer

TARGET AUDIENCE: Physicians, PAs, Advanced Practice Nurses, RNs, Pharmacists

PREREQUISITES: Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization and vaccine-preventable diseases.

FORMAT: This course is Enduring material.

CE Logo In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this Enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for .25 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this knowledge-based event for pharmacists to receive 0.025 CEUs in pharmacy education (0.25 contact hours). The Universal Activity Number is JA4008229-0000-20-181-H06-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

FEES: No fees are charged for CDC’s CE activities.


Continue